Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.

Inflammation and oxidative stress have been implicated in the pathophysiology of Parkinson's disease (PD) and inhibition of microglial activation attenuates degeneration of dopaminergic (DA) neurons in animal models of PD. Loss-of-function mutations in the parkin gene, which encodes an E3 ubiqu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thi A Tran, Andrew D Nguyen, Jianjun Chang, Matthew S Goldberg, Jae-Kyung Lee, Malú G Tansey
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/19fbc2bad9e34893bfeb3afba3b13690
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:19fbc2bad9e34893bfeb3afba3b13690
record_format dspace
spelling oai:doaj.org-article:19fbc2bad9e34893bfeb3afba3b136902021-11-18T06:47:45ZLipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.1932-620310.1371/journal.pone.0023660https://doaj.org/article/19fbc2bad9e34893bfeb3afba3b136902011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21858193/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Inflammation and oxidative stress have been implicated in the pathophysiology of Parkinson's disease (PD) and inhibition of microglial activation attenuates degeneration of dopaminergic (DA) neurons in animal models of PD. Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, cause autosomal recessive parkinsonism. While most studies on Parkin have focused on its function in neurons, here we demonstrate that Parkin mRNA and protein is detectable in brain-resident microglia and peripheral macrophages. Using pharmacologic and genetic approaches, we found that Parkin levels are regulated by inflammatory signaling. Specifically, exposure to LPS or Tumor Necrosis Factor (TNF) induced a transient and dose-dependent decrease in Parkin mRNA and protein in microglia, macrophages and neuronal cells blockable by inhibitors of Nuclear Factor-Kappa B (NF-κB) signaling and not observed in MyD88-null cells. Moreover, using luciferase reporter assays, we identified an NF-κB response element in the mouse parkin promoter responsible for mediating the transcriptional repression, which was abrogated when the consensus sequence was mutated. Functionally, activated macrophages from Parkin-null mice displayed increased levels of TNF, IL-1β, and iNOS mRNA compared to wild type macrophages but no difference in levels of Nrf2, HO-1, or NQO1. One implication of our findings is that chronic inflammatory conditions may reduce Parkin levels and phenocopy parkin loss-of-function mutations, thereby increasing the vulnerability for degeneration of the nigrostriatal pathway and development of PD.Thi A TranAndrew D NguyenJianjun ChangMatthew S GoldbergJae-Kyung LeeMalú G TanseyPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 8, p e23660 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Thi A Tran
Andrew D Nguyen
Jianjun Chang
Matthew S Goldberg
Jae-Kyung Lee
Malú G Tansey
Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.
description Inflammation and oxidative stress have been implicated in the pathophysiology of Parkinson's disease (PD) and inhibition of microglial activation attenuates degeneration of dopaminergic (DA) neurons in animal models of PD. Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, cause autosomal recessive parkinsonism. While most studies on Parkin have focused on its function in neurons, here we demonstrate that Parkin mRNA and protein is detectable in brain-resident microglia and peripheral macrophages. Using pharmacologic and genetic approaches, we found that Parkin levels are regulated by inflammatory signaling. Specifically, exposure to LPS or Tumor Necrosis Factor (TNF) induced a transient and dose-dependent decrease in Parkin mRNA and protein in microglia, macrophages and neuronal cells blockable by inhibitors of Nuclear Factor-Kappa B (NF-κB) signaling and not observed in MyD88-null cells. Moreover, using luciferase reporter assays, we identified an NF-κB response element in the mouse parkin promoter responsible for mediating the transcriptional repression, which was abrogated when the consensus sequence was mutated. Functionally, activated macrophages from Parkin-null mice displayed increased levels of TNF, IL-1β, and iNOS mRNA compared to wild type macrophages but no difference in levels of Nrf2, HO-1, or NQO1. One implication of our findings is that chronic inflammatory conditions may reduce Parkin levels and phenocopy parkin loss-of-function mutations, thereby increasing the vulnerability for degeneration of the nigrostriatal pathway and development of PD.
format article
author Thi A Tran
Andrew D Nguyen
Jianjun Chang
Matthew S Goldberg
Jae-Kyung Lee
Malú G Tansey
author_facet Thi A Tran
Andrew D Nguyen
Jianjun Chang
Matthew S Goldberg
Jae-Kyung Lee
Malú G Tansey
author_sort Thi A Tran
title Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.
title_short Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.
title_full Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.
title_fullStr Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.
title_full_unstemmed Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.
title_sort lipopolysaccharide and tumor necrosis factor regulate parkin expression via nuclear factor-kappa b.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/19fbc2bad9e34893bfeb3afba3b13690
work_keys_str_mv AT thiatran lipopolysaccharideandtumornecrosisfactorregulateparkinexpressionvianuclearfactorkappab
AT andrewdnguyen lipopolysaccharideandtumornecrosisfactorregulateparkinexpressionvianuclearfactorkappab
AT jianjunchang lipopolysaccharideandtumornecrosisfactorregulateparkinexpressionvianuclearfactorkappab
AT matthewsgoldberg lipopolysaccharideandtumornecrosisfactorregulateparkinexpressionvianuclearfactorkappab
AT jaekyunglee lipopolysaccharideandtumornecrosisfactorregulateparkinexpressionvianuclearfactorkappab
AT malugtansey lipopolysaccharideandtumornecrosisfactorregulateparkinexpressionvianuclearfactorkappab
_version_ 1718424337324703744